These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6791002)

  • 1. Overview of human pharmacokinetics of naltrexone.
    Licko V
    NIDA Res Monogr; 1981; 28():161-71. PubMed ID: 6791002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone disposition in man after subcutaneous administration.
    Wall ME; Perez-Reyes M; Brine DR; Cook CE
    Drug Metab Dispos; 1984; 12(6):677-82. PubMed ID: 6150815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME; Brine DR; Perez-Reyes M
    Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of naloxone and naltrexone in the dog.
    Pace NL; Parrish RG; Lieberman MM; Wong KC; Blatnick RA
    J Pharmacol Exp Ther; 1979 Feb; 208(2):254-6. PubMed ID: 762657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the oral, intravenous, and subcutaneous administration of 3H-naltrexone to normal male volunteers.
    Perez-Reyes M; Wall ME
    NIDA Res Monogr; 1981; 28():93-101. PubMed ID: 6791016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.
    Verebey K
    NIDA Res Monogr; 1981; 28():147-58. PubMed ID: 6791001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs.
    Ludden TM; Bathala MS; Malspeis L; Drum MA; Reuning RH
    Drug Metab Dispos; 1978; 6(3):321-8. PubMed ID: 26554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of a naltrexone sustained-release preparation.
    Chiang CN; Hollister LE; Kishimoto A; Barnett G
    Clin Pharmacol Ther; 1984 Nov; 36(5):704-8. PubMed ID: 6488691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the systemic availability and other pharmacokinetic parameters of naltrexone in man after acute and chronic oral administration.
    Kogan MJ; Verebey K; Mule SJ
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):29-34. PubMed ID: 905632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of naltrexone in man.
    Wall ME; Brine DR; Perez-Reyes M
    NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification and measurement of two new metabolites of naltrexone in human urine.
    Cone EJ; Gorodetzky CW; Darwin WD; Carroll FI; Brine GA; Welch CD
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):413-33. PubMed ID: 674824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and semen kinetics of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    Proc West Pharmacol Soc; 1979; 22():455-61. PubMed ID: 515087
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of preclinical research on disposition, pharmacokinetics, and metabolism of naltrexone.
    Misra AL
    NIDA Res Monogr; 1981; 28():132-46. PubMed ID: 6267469
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma naltrexone kinetics after intravenous bolus administration in dogs and monkeys.
    Reuning RH; Batra VK; Ludden TM; Jao MY; Morrison BE; McCarthy DA; Harrigan SE; Ashcraft SB; Sams RA; Bathala MS; Staubus AE; Malspeis L
    J Pharm Sci; 1979 Apr; 68(4):411-6. PubMed ID: 108382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.
    Misra AL; Bloch R; Vardy J; Mulé SJ; Verebely K
    Drug Metab Dispos; 1976; 4(3):276-80. PubMed ID: 6233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and identification of a new metabolite of naltrexone in human blood and urine.
    Verebely K; Chedekel MA; Mule SJ; Rosenthal D
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):67-84. PubMed ID: 1188187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.